Palash Tzvi 4
4 · Protalix BioTherapeutics, Inc. · Filed Sep 7, 2010
Insider Transaction Report
Form 4
Palash Tzvi
Chief Operating Officer
Transactions
- Award
Stock Options (Right to Buy)
2010-08-29+160,000→ 160,000 totalExercise: $7.55Exp: 2020-08-29→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The options vest over a four-year period. The first 25% of the options vest on the first anniversary of the grant date and the remaining 75% of the options vest in 12 equal tranches on a quarterly basis during the subsequent three-year period.